Obeticholic acid demonstrates sustained improvements at month 24 in transaminases and non-invasive markers of fibrosis: Results of a post hoc analysis from the interim analysis of the REGENERATE study. (March 2021) - Loomba, R.; Ratziu, V.; Anstee, Q.M.; Harrison, S.; Sanyal, A.J.; Rinella, M.; Younossi, Z.Y.; Goodman, Z.; Bedossa, P.; Shringarpure, R.; Zhou, H.; Noureddin, M.; et al.